HotSheets by Year

 

HotSheets 2008

  • Overall Survival Analysis of SPARC Trial
  • Patients Often Get Contraindicated Therapy
  • Us TOO’s 2008 Board Members/Officers
  • Post-Prostatectomy Incontinence Treatment
  • Letter to the Editor
  • Doc Moyad’s What Works and What is Worthless Column—Statins
  • Read more..
  • Senate Passes Last-Minute ‘Rescue” for Doctors Facing Big Medicare Cuts
  • Aspirin Impairs Prostate Cancer Treatment
  • More FDA Action Possible for ESAs
  • Cancer Tool Shows Promise in Scottsdale
  • Hormones Delay Prostate Cancer Growth
  • Research Yields Clues to Cancer Recurrence
  • Read more..
  • Supreme Court Declines Review in the Abigail Alliance Experimental Drug Case
  • Editorial: Provenge Pressure Builds on FDA
  • Cell Genesys’ Clinical Trials to Continue
  • Supreme Court Sides with Washington University in Tissue Ownership Case
  • No Link Between Androgen and Risk for PCa
  • Us TOO Raises Minority Cancer Awareness
  • Read more..
  • Special Burning Issues Supplement: Highlights from ASCO’s 2008 Genitourinary Cancers Symposium—San Francisco, CA, February 14-16, 2008
  • New Analysis Out on Cancer Drug
  • GTx’s Toremifene Meets Primary Endpoints
  • Treatment Decision-Making Not Easy
  • The Power of Words for Cancer Patients
  • April Brings a New Look to SEA Blue for National Minority Cancer Awareness Week
  • Genetic Variants Found to be Associated with Prostate Cancer
  • Read more..
  • Doctors Use “GPS for the Body” to Target Cancer Cells
  • Takeda, Cell Genesys Partner to Develop Prostate Cancer Vaccine
  • Blood Test Indicates Nodal Spread in Localized Prostate Cancer
  • Medicare Changes Influenced Prostate Cancer Treatment Decisions
  • New Information Drives Changes in Bladder Control Treatment
  • Outer–Course vs. Inter-Course
  • Geneve Bio Developing Revolutionary Curative ED Treatment
  • Read more..
  • Experimental Vaccine Shows Promise in Prostate Cancer
  • Celebrex-Lipitor Combination May Halt Prostate Cancer
  • Prostate Cancer Mortality Declining Faster in the United States than in Britain
  • Iowa, Arizona Expand on SEA Blue African American Awareness Campaign
  • Similar Survival with Salvage Surgery (RP) and Radiotherapy (RT)
  • Gene Activity and Cancer’s Racial Divide
  • Nanotechnology Enhances Early Detection of Prostate Cancer in Black Males
  • Read more..
  • New Analysis Boost’s Finasteride’s Value
  • Active Surveillance Still a Viable Option
  • Adjuvant Radiation Shows Promise for High-Risk Surgery Patients
  • Kennedy Has Major Cancer Bill in Senate
  • Prostate Cancer Vaccine Linked to Improved Survival in Small Trial
  • Amgen Reports Positive Data at ASCO for Denosumab in Cancer Patients
  • ‘Equivocal’ Antioxidant Effects in Cancer Therapy
  • Read more..
  • Pints for Prostates Delivers Men’s Health Message
  • Mrs. Illinois 2008 Supports Prostate Cancer Awareness and Us TOO International
  • Proscar® Lowers Prostate Cancer Risk in All Men
  • Radiation May Help After Prostate Cancer Setback
  • GPC Biotech Announces NCI-Sponsored Phase 2 Trial of Satraplatin in Metastatic HRPC
  • Doc Moyad’s “What Works and What Is Worthless Column”—Saturated Fat
  • Read more..
  • Prostate Test Advice for Elderly Won’t Stop Debate
  • First Annual Edward C. Kaps Hope Award Winners Announced
  • Amgen Announces Positive Results for Denosumab
  • Do You Know Where Your Prostate Cancer Tissue Is?
  • Early Findings Create Buzz for Potent Novel Hormone Blocker
  • Us TOO Seeks Board Member Nominations
  • Read more..
  • Cell Genesys Halts GVAX Trial
  • The Wrong Call on Prostate Cancer Screening
  • Blood Calcium Tied to Lethal Prostate Cancer
  • Researchers Find Prostate Cancer Gene
  • Regular NSAID Use May Reduce PSA Levels
  • 2nd Annual Cancer Awareness Days in NJ
  • Doc Moyad’s "What Works and What Is Worthless Column"— I.V. Vitamin C
  • Read more..
  • Radiation Added to Androgen Deprivation Therapy Halves Risk of Prostate Cancer Death
  • Dendreon Announces Interim Data from Phase 3 Provenge IMPACT Trial
  • Novacea Has No Plans to Develop Asentar®
  • Understanding Scientific Studies & Reports – Determining What’s Good & What’s Not
  • The Patient as Healer – How to Alleviate Your Pain and Stress
  • Proton Radiation Fails to Impress in Prostate Cancer Study
  • Read more..
  • Cell Genesis Announces Termination of Phase 3 VITAL-1 GVAX Clinical Trial
  • Vitamin E and Selenium Do Not Prevent Prostate Cancer: Large-Scale Study Stopped
  • AUA Best Practice Statement Recommends Cryosurgery in Certain Prostate Cancer
  • Rethinking Prostate Cancer in Older Men
  • Prostate Cancer Awareness Events: Greater Chicago Prostate Cancer Run Walk ‘n Roll
  • Lawyer, Mountain Climber Names Us TOO As Beneficiary
  • Read more..

CLICK HERE and opt-in to receive free educational emails from Us TOO.